MENUNews Archive
Date: 04/03/2012
Pathology evaluations done on-site cut operating time, reduced cost, study shows. Resulting in fewer women needing repeat breast cancer surgeries." />
Date: 04/02/2012
Arul M. Chinnaiyan, M.D., Ph.D., of the University of Michigan Rogel Cancer Center will lead the Dream Team project titled Precision Therapy for Advanced Prostate Cancer.
Date: 03/27/2012
Dr. Sofia Merajver, an expert on breast and ovarian cancer genetics, is available to discuss U.S. Supreme Court developments in Myriad Genetics case.
Date: 03/20/2012
In time for Colorectal Cancer Awareness Month, University of Michigan Rogel Cancer Center experts outline genetic counseling, screening and treatment strategies for colorectal cancer.
Date: 03/14/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Date: 03/13/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Date: 02/29/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Rogel Cancer Center for three weeks in March.
Date: 02/29/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Rogel Cancer Center for three weeks in March.
Date: 02/16/2012
National Institute of Health names University of Michigan anesthesiologist Carman Green, M.D. to new Interagency Pain Research Coordinating Committee.
Date: 02/10/2012
Cancer research depends on people volunteering to participate in clinical studies.